Application

17075496 · SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE

Filed 2020-10-20 · Granted · Patent 11583536 (2023-02-21) The official file ↗The patent and its PDF ↗ · Art unit 1627 · Examiner Sarah Pihonak Typical · CPC A61P 35/00 · Celgene Corporation · Celegene Corporation

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

14.8 mo

to disposition 28.1 mo

Statutes raised

103 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.